Dbv technologies receives requested feedback from fda on protocol design elements for comfort safety studies and reports third quarter 2023 financial results

Montrouge, france, october 31, 2023 dbv technologies receives requested feedback from fda on protocol design elements for comfort safety studies and reports third quarter 2023 financial results dbv has received written feedback from the u.s. food and drug administration (fda) clarifying design elements for both the comfort toddlers and comfort children supplemental safety studies. both supplemental safety studies will have harmonized, simplified protocol language on how the product should be used.
DBVT Ratings Summary
Quant
DBVT Quant Ranking
Sector
Industry
Quant Rating
Quant Score